ASTS
AST SpaceMobile, Inc.
ASTS has slightly lower modeled downside risk, despite its lower overall score.
CPSH
CPS Technologies Corporation
CPSH has a slight edge over ASTS overall on the model score.
ASTS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
ASTS's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
CPSH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Weak | |
| Strong |
CPSH's balance sheet is currently strong, and its revenue and profitability are stable, but its cash flow is weak.
ASTS PE Valuation
ASTS has no meaningful PE right now: it lost money over the past year.
CPSH PE Valuation
CPSH has no meaningful PE right now: it lost money over the past year.
ASTS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect ASTS's losses to grow, with revenue growing. However, they disagree widely on these estimates.
CPSH Forward outlook
There aren't enough analyst estimates for CPSH to show an outlook.
ASTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.15 | -$0.91 |
| Q2 2026 | -$2.16 | -$0.27 |
| Q1 2026 | -$1.80 | +$0.19 |
| Q4 2025 | -$1.34 | +$0.61 |
| Q3 2025 | -$1.24 | +$0.88 |
| Q2 2025 | -$1.89 | -$0.64 |
| Q1 2025 | -$1.99 | -$1.01 |
| Q4 2022 | -$0.58 | -$0.21 |
ASTS is still losing money, but far less than before: $2.15 per share over the past year, against $5.76 at its worst in mid-2021.
CPSH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.00 | +$0.04 |
| Q2 2026 | -$0.01 | +$0.11 |
| Q1 2026 | $0.00 | +$0.20 |
| Q4 2025 | $0.03 | +$0.25 |
| Q3 2025 | -$0.04 | +$0.10 |
| Q2 2025 | -$0.12 | -$0.06 |
| Q1 2025 | -$0.20 | -500% |
| Q4 2024 | -$0.22 | -344% |
CPSH has the edge over ASTS on earnings, with more consistent year-over-year improvement.
ASTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $42.3M | +187% |
| Q2 2026 | $31.5M | +2627% |
| Q1 2026 | $14.7M | +1952% |
| Q4 2025 | $54.3M | +2731% |
| Q3 2025 | $14.7M | +1240% |
| Q2 2025 | $1.2M | +28% |
| Q1 2025 | $718K | +44% |
| Q3 2022 | $4.2M | +70% |
ASTS has the edge over CPSH on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -415% | +694 points |
| Q2 2026 | -948% | +10744 points |
| Q1 2026 | -1686% | +7083 points |
| Q4 2025 | -175% | +2446 points |
| Q3 2025 | -1109% | +4850 points |
| Q2 2025 | -11692% | -4693 points |
| Q1 2025 | -8769% | +2331 points |
| Q4 2024 | -2621% | N/A |
ASTS's operating margin was −415% last quarter, up 694 points from the same quarter a year ago.
CPSH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $8.9M | +1.1% |
| Q2 2026 | $8.3M | +2.9% |
| Q1 2026 | $7M | -6.4% |
| Q4 2025 | $8.2M | +38% |
| Q3 2025 | $8.8M | +107% |
| Q2 2025 | $8.1M | +61% |
| Q1 2025 | $7.5M | +27% |
| Q4 2024 | $5.9M | -12% |
CPSH's revenue is growing: $9M last quarter, up 1.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 4% | +0.9 points |
| Q2 2026 | -3.1% | -4.8 points |
| Q1 2026 | -7.4% | -9.2 points |
| Q4 2025 | -1.2% | +21 points |
| Q3 2025 | 3.1% | +38 points |
| Q2 2025 | 1.7% | +28 points |
| Q1 2025 | 1.7% | +6.1 points |
| Q4 2024 | -22% | -24 points |
CPSH has the edge over ASTS on profitability, with a higher operating margin.
ASTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$464.2M | -$161.4M |
| Q2 2026 | -$694.8M | -$341.1M |
| Q1 2026 | -$309.7M | -$160.7M |
| Q4 2025 | -$330.7M | -$220.3M |
| Q3 2025 | -$302.9M | -$239.1M |
| Q2 2025 | -$353.6M | -$315.3M |
| Q1 2025 | -$149M | -$61.3M |
| Q4 2024 | -$110.5M | -$63.2M |
ASTS has burned cash in almost every quarter: −$1.8B over the past year, against −$916M the year before.
CPSH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$310.2K | -135% |
| Q2 2026 | -$2.4M | -601% |
| Q1 2026 | -$767.8K | +$578K |
| Q4 2025 | -$494.4K | +$974.6K |
| Q3 2025 | $876.8K | +$2.1M |
| Q2 2025 | $476.4K | +$2.1M |
| Q1 2025 | -$1.3M | -$1.2M |
| Q4 2024 | -$1.5M | -3294% |
CPSH has the edge over ASTS on cash flow, with more consistent year-over-year improvement.
ASTS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +1.1M shares |
| 1 year | +10% | +27.3M shares |
| 3 years | +235% | +211M shares |
| 5 years | +480% | +248M shares |
| Available history | +944% | +271M shares |
ASTS has the edge over CPSH on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
CPSH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +4.8% | +903K shares |
| 1 year | +35% | +5.1M shares |
| 3 years | +35% | +5.1M shares |
| 5 years | +33% | +4.9M shares |
| Available history | +50% | +6.6M shares |
CPSH has 20M diluted shares, up 35% from a year ago.
ASTS Net Leverage
ASTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CPSH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -36.2x | Net Cash |
| Q1 2026 | -15.1x | Net Cash |
| Q4 2025 | -4.3x | Net Cash |
| Q1 2024 | -7.1x | Net Cash |
| Q4 2023 | -4.0x | Net Cash |
| Q3 2023 | -3.7x | Net Cash |
| Q2 2023 | -2.9x | Net Cash |
| Q1 2023 | -2.6x | Net Cash |
CPSH has more cash than debt.
ASTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.1 | Neutral |
| Stochastic | 11.9 | Oversold |
ASTS's weekly RSI is 34 (neutral) and its Stochastic is 12 (oversold).
CPSH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 48.8 | Neutral |
| Stochastic | 36.9 | Neutral |
CPSH's weekly RSI is 49 (neutral) and its Stochastic is 37 (neutral).
ASTS PE vs Technology Sector
ASTS has no meaningful PE right now: it lost money over the past year.
CPSH PE vs Technology Sector
| Metric | CPSH | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
CPSH has no meaningful PE right now: it lost money over the past year.
ASTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.9 | 23% below |
| 20 week MA | $57.1 | 40% below |
| 50 week MA | $75.5 | 54% below |
| 100 week MA | $57.8 | 40% below |
| 200 week MA | $33.6 | 2.8% above |
ASTS has fallen below most of its moving averages, though it's still 2.8% above its 200-week average.
CPSH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.72 | 10% above |
| 20 week MA | $4.04 | 1.5% above |
| 50 week MA | $4.51 | 9.1% below |
| 100 week MA | $3.52 | 16% above |
| 200 week MA | $2.89 | 42% above |
CPSH has the edge over ASTS on trend strength, trading above more of its moving averages.
ASTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.87 | $13.4 | +36% |
| 2021 | $13.4 | $8.71 | -35% |
| 2022 | $8.71 | $3.97 | -54% |
| 2023 | $3.97 | $6.03 | +52% |
| 2024 | $6.03 | $22.9 | +280% |
| 2025 | $22.9 | $72.0 | +214% |
| 2026 YTD | $72.0 | $34.5 | -52% |
ASTS's yearly returns have swung widely, from +280% in 2024 to −54% in 2022. It's down 52% so far in 2026.
CPSH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.05 | $2.29 | +118% |
| 2021 | $2.29 | $4.34 | +90% |
| 2022 | $4.34 | $2.75 | -37% |
| 2023 | $2.75 | $2.35 | -15% |
| 2024 | $2.35 | $1.62 | -31% |
| 2025 | $1.62 | $3.21 | +98% |
| 2026 YTD | $3.21 | $4.10 | +28% |
CPSH has the edge over ASTS on returns for 2026, with the stronger performance.